A fast-acting, modular-structured staphylokinase fusion with Kringle-1 from human plasminogen as the fibrin-targeting domain offers improved clot lysis efficacy.

MLA

Wu, Sau-Ching, et al. “A Fast-Acting, Modular-Structured Staphylokinase Fusion with Kringle-1 from Human Plasminogen as the Fibrin-Targeting Domain Offers Improved Clot Lysis Efficacy.” The Journal of Biological Chemistry, vol. 278, no. 20, May 2003, pp. 18199–206. EBSCOhost, https://doi.org/10.1074/jbc.M210919200.

APA

Wu, S.-C., Castellino, F. J., & Wong, S.-L. (2003). A fast-acting, modular-structured staphylokinase fusion with Kringle-1 from human plasminogen as the fibrin-targeting domain offers improved clot lysis efficacy. The Journal of Biological Chemistry, 278(20), 18199–18206. https://doi.org/10.1074/jbc.M210919200

Chicago

Wu, Sau-Ching, Francis J Castellino, and Sui-Lam Wong. 2003. “A Fast-Acting, Modular-Structured Staphylokinase Fusion with Kringle-1 from Human Plasminogen as the Fibrin-Targeting Domain Offers Improved Clot Lysis Efficacy.” The Journal of Biological Chemistry 278 (20): 18199–206. doi:10.1074/jbc.M210919200.